Evidence – Building Integrated Development Strategies to Improve Development Time-lines & Reduce Late-Stage Risks
2:40 pm - Thursday 3rd December 2026
- Reducing late-stage risk by integrating decision making across biology, pharmacology and regulatory functions
- Aligning model selection, biomarker strategy, PK/PD understanding, formulation and regulatory planning earlier in development
- Updating ‘traditional’ organisation structures to improve communication between discovery, translational, and clinical and regulatory functions
